Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Synthesis and Fabrication of Surface-Active Microparticles Using a Membrane Emulsion Technique and Conjugation of Model Protein via Strain-Promoted Azide-Alkyne Click Chemistry in Physiological Conditions.

Walden G, Liao X, Riley G, Donell S, Raxworthy MJ, Saeed A.

Bioconjug Chem. 2019 Mar 20;30(3):531-535. doi: 10.1021/acs.bioconjchem.8b00868. Epub 2019 Feb 11.

PMID:
30730698
2.

A Clinical, Biological, and Biomaterials Perspective into Tendon Injuries and Regeneration.

Walden G, Liao X, Donell S, Raxworthy MJ, Riley GP, Saeed A.

Tissue Eng Part B Rev. 2017 Feb;23(1):44-58. doi: 10.1089/ten.TEB.2016.0181. Epub 2016 Sep 30.

3.

A three-dimensional model of primary bovine endometrium using an electrospun scaffold.

MacKintosh SB, Serino LP, Iddon PD, Brown R, Conlan RS, Wright CJ, Maffeis TG, Raxworthy MJ, Sheldon IM.

Biofabrication. 2015 May 28;7(2):025010. doi: 10.1088/1758-5090/7/2/025010.

PMID:
26019144
4.

Evidence for a novel glutamate-mediated signaling pathway in keratinocytes.

Genever PG, Maxfield SJ, Kennovin GD, Maltman J, Bowgen CJ, Raxworthy MJ, Skerry TM.

J Invest Dermatol. 1999 Mar;112(3):337-42.

5.

Integrin receptor involvement in actin cable formation in an in vitro model of events associated with wound contraction.

Stephens P, Genever PG, Wood EJ, Raxworthy MJ.

Int J Biochem Cell Biol. 1997 Jan;29(1):121-8.

PMID:
9076946
6.

Development of a multilayered in vitro model for studying events associated with wound healing.

Stephens P, Wood EJ, Raxworthy MJ.

Wound Repair Regen. 1996 Jul-Sep;4(3):393-401.

PMID:
17177738
7.

Fabrication and reorganization of dermal equivalents suitable for skin grafting after major cutaneous injury.

Rowling PJ, Raxworthy MJ, Wood EJ, Kearney JN, Cunliffe WJ.

Biomaterials. 1990 Apr;11(3):181-5.

PMID:
2350555
8.

Crosslinked fibrous collagen for use as a dermal implant: control of the cytotoxic effects of glutaraldehyde and dimethylsuberimidate.

Hey KB, Lachs CM, Raxworthy MJ, Wood EJ.

Biotechnol Appl Biochem. 1990 Feb;12(1):85-93.

PMID:
2106902
9.

Biological skin equivalent.

Rowling PJ, Raxworthy MJ, Wood EJ, Kearny JN, Cunliffe WJ.

Burns Incl Therm Inj. 1989 Feb;15(1):64. No abstract available.

PMID:
2541874
10.

Retinoids and the epidermis.

Wood EJ, Raxworthy MJ, Holland DB.

Biochem Soc Trans. 1988 Oct;16(5):668-71. Review. No abstract available.

PMID:
2466710
11.

An alteration in tubulin expression detected in SV40 transformed 3T3 cells.

Raxworthy MJ, Shaw JR, Marriott MS.

Cell Biol Int Rep. 1986 Jul;10(7):555-63.

PMID:
3015424
12.
13.

Catechol-O-methyltransferase: substrate-specificity and stereoselectivity for beta-adrenoceptor agents.

Raxworthy MJ, Youde IR, Gulliver PA.

Xenobiotica. 1986 Jan;16(1):47-52.

PMID:
2868577
14.
15.

The inhibition of catechol-O-methyltransferase by 2,3-dihydroxypyridine.

Raxworthy MJ, Youde IR, Gulliver PA.

Biochem Pharmacol. 1983 Apr 15;32(8):1361-4.

PMID:
6860355
16.

The cellular location of catechol-O-methyltransferase in rat liver.

Raxworthy MJ, Gulliver PA, Hughes PJ.

Naunyn Schmiedebergs Arch Pharmacol. 1982 Aug;320(2):182-8.

PMID:
7121616
17.
18.
19.

Benserazide and carbidopa as substrates of catechol-O-methyltransferase: new mechanism of action in Parkinson's disease.

Hagan RM, Raxworthy MJ, Gulliver PA.

Biochem Pharmacol. 1980 Dec 1;29(23):3123-6. No abstract available.

PMID:
7447951

Supplemental Content

Loading ...
Support Center